Skip to main content

Find Clinical Trials

Home
Conditions
Microsatellite Stable (MSS) Colorectal Cancer (CRC)

Clinical trial condition

Microsatellite Stable (MSS) Colorectal Cancer (CRC)

Explore clinical trials studying Microsatellite Stable (MSS) Colorectal Cancer (CRC). Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Microsatellite Stable (MSS) Colorectal Cancer (CRC) trial results

Not Yet Recruiting

FOLFIRI Plus Bevacizuamb and QL1706 in Second-Line Treatment for mCRC

NCT07729605

Conditions: Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +20 more
Locations: The sixth affiliated hospital of Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.

NCT06835179

Conditions: Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +21 more
Locations: Not specified

View Trial Details

Active, Not Recruiting

Trial of Atezolizumab, Bevacizumab, and Tiragolumab in Patients With Microsatellite Stable, Metastatic Colorectal Cancer

NCT06784947

Conditions: Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +21 more
Locations: Universtiy of Colorado Hospital Aurora, Colorado, United States

View Trial Details